Antibody-drug conjugates (adcs) having enzymatically cleavable groups

The invention relates to novel binder-drug conjugates (ADCs) having improved properties, to active metabolites of these ADCs and to processes for their preparation. The present invention furthermore relates to the use of these conjugates for the treatment and/or prevention of diseases and to the use...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STELTE-LUDWIG, BEATRIX, KIRCHHOFF, DENNIS, MAERSCH, STEPHAN, REBSTOCK, ANNE-SOPHIE, SOMMER, ANETTE, HAMMER, STEFANIE, BERNDT, SANDRA, MAHLERT, CHRISTOPH, DIETZ, LISA, LERCHEN, HANS-GEORG, GREVEN, SIMONE
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to novel binder-drug conjugates (ADCs) having improved properties, to active metabolites of these ADCs and to processes for their preparation. The present invention furthermore relates to the use of these conjugates for the treatment and/or prevention of diseases and to the use of these conjugates for preparing medicaments for treatment and/or prevention of diseases, in particular hyperproliferative and/or angiogenic disorders such as, for example, cancer diseases.